ACHV
Price
$3.83
Change
+$0.30 (+8.50%)
Updated
Jun 6 closing price
Capitalization
122.26M
60 days until earnings call
HOFBF
Price
$0.15
Change
+$0.06 (+60.00%)
Updated
Apr 14 closing price
Capitalization
86.49M
Interact to see
Advertisement

ACHV vs HOFBF

Header iconACHV vs HOFBF Comparison
Open Charts ACHV vs HOFBFBanner chart's image
Achieve Life Sciences
Price$3.83
Change+$0.30 (+8.50%)
Volume$244.73K
Capitalization122.26M
Hofseth Biocare ASA
Price$0.15
Change+$0.06 (+60.00%)
Volume$400
Capitalization86.49M
ACHV vs HOFBF Comparison Chart
Loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACHV vs. HOFBF commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Buy and HOFBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (ACHV: $3.15 vs. HOFBF: $0.16)
Brand notoriety: ACHV and HOFBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 75% vs. HOFBF: 6%
Market capitalization -- ACHV: $122.26M vs. HOFBF: $86.49M
ACHV [@Biotechnology] is valued at $122.26M. HOFBF’s [@Biotechnology] market capitalization is $86.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green whileHOFBF’s FA Score has 0 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • HOFBF’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACHV and HOFBF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 5 TA indicator(s) are bullish.

  • ACHV’s TA Score: 5 bullish, 4 bearish.

Price Growth

ACHV (@Biotechnology) experienced а +0.32% price change this week, while HOFBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ACHV is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACHV($122M) has a higher market cap than HOFBF($86.5M). HOFBF YTD gains are higher at: 55.000 vs. ACHV (-10.511). ACHV has higher annual earnings (EBITDA): -37.42M vs. HOFBF (-67.94M). ACHV has more cash in the bank: 34.3M vs. HOFBF (25.6M). ACHV has less debt than HOFBF: ACHV (9.96M) vs HOFBF (171M). HOFBF has higher revenues than ACHV: HOFBF (257M) vs ACHV (0).
ACHVHOFBFACHV / HOFBF
Capitalization122M86.5M141%
EBITDA-37.42M-67.94M55%
Gain YTD-10.51155.000-19%
P/E RatioN/AN/A-
Revenue0257M-
Total Cash34.3M25.6M134%
Total Debt9.96M171M6%
FUNDAMENTALS RATINGS
ACHV vs HOFBF: Fundamental Ratings
ACHV
HOFBF
OUTLOOK RATING
1..100
1230
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
79
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4940
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACHV's Valuation (72) in the Biotechnology industry is in the same range as HOFBF (79) in the null industry. This means that ACHV’s stock grew similarly to HOFBF’s over the last 12 months.

ACHV's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as HOFBF (100) in the null industry. This means that ACHV’s stock grew similarly to HOFBF’s over the last 12 months.

ACHV's SMR Rating (100) in the Biotechnology industry is in the same range as HOFBF (100) in the null industry. This means that ACHV’s stock grew similarly to HOFBF’s over the last 12 months.

HOFBF's Price Growth Rating (40) in the null industry is in the same range as ACHV (49) in the Biotechnology industry. This means that HOFBF’s stock grew similarly to ACHV’s over the last 12 months.

HOFBF's P/E Growth Rating (100) in the null industry is in the same range as ACHV (100) in the Biotechnology industry. This means that HOFBF’s stock grew similarly to ACHV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHV
RSI
ODDS (%)
Bearish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
87%
Momentum
ODDS (%)
Bullish Trend 12 days ago
80%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
71%
Advances
ODDS (%)
Bullish Trend 21 days ago
81%
Declines
ODDS (%)
Bearish Trend 18 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
90%
Aroon
ODDS (%)
Bullish Trend 12 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been closely correlated with HOFBF. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if ACHV jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-0.32%
HOFBF - ACHV
72%
Closely correlated
N/A
ABOS - ACHV
43%
Loosely correlated
N/A
EYPT - ACHV
40%
Loosely correlated
+18.12%
ERAS - ACHV
40%
Loosely correlated
+1.85%
ATOS - ACHV
39%
Loosely correlated
-3.13%
More

HOFBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOFBF has been closely correlated with ACHV. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if HOFBF jumps, then ACHV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOFBF
1D Price
Change %
HOFBF100%
N/A
ACHV - HOFBF
72%
Closely correlated
-0.32%
COGT - HOFBF
63%
Loosely correlated
N/A
KROS - HOFBF
38%
Loosely correlated
+2.02%
XFOR - HOFBF
35%
Loosely correlated
-4.13%
UBX - HOFBF
33%
Loosely correlated
-7.71%
More